192 related articles for article (PubMed ID: 38345134)
1. Hypoxia-informed RBE-weighted beam orientation optimization for intensity modulated proton therapy.
Ramesh P; Ruan D; Liu SJ; Seo Y; Braunstein S; Sheng K
Med Phys; 2024 Mar; 51(3):2320-2333. PubMed ID: 38345134
[TBL] [Abstract][Full Text] [Related]
2. Reformulated McNamara RBE-weighted beam orientation optimization for intensity modulated proton therapy.
Ramesh P; Lyu Q; Gu W; Ruan D; Sheng K
Med Phys; 2022 Apr; 49(4):2136-2149. PubMed ID: 35181892
[TBL] [Abstract][Full Text] [Related]
3. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
4. Combined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET.
Henjum H; Dahle TJ; Mairani A; Pilskog S; Stokkevåg C; Boer CG; Redalen KR; Minn H; Malinen E; Ytre-Hauge KS
J Appl Clin Med Phys; 2023 Sep; 24(9):e14014. PubMed ID: 37161820
[TBL] [Abstract][Full Text] [Related]
5. Robust beam orientation optimization for intensity-modulated proton therapy.
Gu W; Neph R; Ruan D; Zou W; Dong L; Sheng K
Med Phys; 2019 Aug; 46(8):3356-3370. PubMed ID: 31169917
[TBL] [Abstract][Full Text] [Related]
6. Linear energy transfer weighted beam orientation optimization for intensity-modulated proton therapy.
Gu W; Ruan D; Zou W; Dong L; Sheng K
Med Phys; 2021 Jan; 48(1):57-70. PubMed ID: 32542711
[TBL] [Abstract][Full Text] [Related]
7. Impact of potentially variable RBE in liver proton therapy.
Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
[TBL] [Abstract][Full Text] [Related]
9. The FLUKA Monte Carlo code coupled with an OER model for biologically weighted dose calculations in proton therapy of hypoxic tumors.
Dahle TJ; Rusten E; Stokkevåg CH; Silvoniemi A; Mairani A; Fjæra LF; Rørvik E; Henjum H; Wright P; Boer CG; Forsback S; Minn H; Malinen E; Ytre-Hauge KS
Phys Med; 2020 Aug; 76():166-172. PubMed ID: 32683269
[TBL] [Abstract][Full Text] [Related]
10. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
11. Deterministic direct aperture optimization using multiphase piecewise constant segmentation.
Nguyen D; O'Connor D; Ruan D; Sheng K
Med Phys; 2017 Nov; 44(11):5596-5609. PubMed ID: 28834556
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
[TBL] [Abstract][Full Text] [Related]
13. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
[TBL] [Abstract][Full Text] [Related]
14. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
[TBL] [Abstract][Full Text] [Related]
15. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
[TBL] [Abstract][Full Text] [Related]
16. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia adapted relative biological effectiveness models for proton therapy: a simulation study.
Garrido-Hernandez G; Henjum H; Høiskar MK; Dahle TJ; Redalen KR; Ytre-Hauge KS
Biomed Phys Eng Express; 2022 Nov; 8(6):. PubMed ID: 36260973
[TBL] [Abstract][Full Text] [Related]
18. A unified path seeking algorithm for IMRT and IMPT beam orientation optimization.
Ramesh P; Valdes G; O'Connor D; Sheng K
Phys Med Biol; 2023 Sep; 68(19):. PubMed ID: 37659406
[No Abstract] [Full Text] [Related]
19. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
20. Quantification of biological range uncertainties in patients treated at the Krakow proton therapy centre.
Garbacz M; Gajewski J; Durante M; Kisielewicz K; Krah N; Kopeć R; Olko P; Patera V; Rinaldi I; Rydygier M; Schiavi A; Scifoni E; Skóra T; Skrzypek A; Tommasino F; Rucinski A
Radiat Oncol; 2022 Mar; 17(1):50. PubMed ID: 35264184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
